DE69939894D1 - Behandlung der dysurie - Google Patents

Behandlung der dysurie

Info

Publication number
DE69939894D1
DE69939894D1 DE69939894T DE69939894T DE69939894D1 DE 69939894 D1 DE69939894 D1 DE 69939894D1 DE 69939894 T DE69939894 T DE 69939894T DE 69939894 T DE69939894 T DE 69939894T DE 69939894 D1 DE69939894 D1 DE 69939894D1
Authority
DE
Germany
Prior art keywords
diseases
urinary tract
disorders
treatment
tract system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69939894T
Other languages
English (en)
Inventor
Tamio Yamauchi
Tomohiro Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69939894D1 publication Critical patent/DE69939894D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69939894T 1998-11-05 1999-11-05 Behandlung der dysurie Expired - Lifetime DE69939894D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31436998 1998-11-05
JP3977999 1999-02-18
PCT/JP1999/006170 WO2000027383A1 (fr) 1998-11-05 1999-11-05 Medicaments contre la dysurie

Publications (1)

Publication Number Publication Date
DE69939894D1 true DE69939894D1 (de) 2008-12-24

Family

ID=26379168

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69939894T Expired - Lifetime DE69939894D1 (de) 1998-11-05 1999-11-05 Behandlung der dysurie

Country Status (10)

Country Link
US (1) US6329428B1 (de)
EP (1) EP1055426B1 (de)
JP (1) JP3507439B2 (de)
KR (1) KR100375003B1 (de)
CN (1) CN1224384C (de)
AT (1) ATE413869T1 (de)
AU (1) AU734793B2 (de)
CA (1) CA2317530C (de)
DE (1) DE69939894D1 (de)
WO (1) WO2000027383A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4015954B2 (ja) * 2001-04-16 2007-11-28 大鵬薬品工業株式会社 トシル酸スプラタスト結晶
EP1405638B1 (de) * 2001-07-10 2011-02-09 Astellas Pharma Inc. Pharmazeutische zusammensetzung enthaltend quinuclidin-3'-yl 1-phenyl-1,2,3,4,-tetrahydroisoquinolin-2-carboxylat zur behandlung der interstitiellen cystitis und/oder der abakteriellen prostatitis
JP3921664B2 (ja) * 2002-10-29 2007-05-30 大鵬薬品工業株式会社 非細菌性前立腺炎モデル動物
JP4794148B2 (ja) * 2004-09-10 2011-10-19 大鵬薬品工業株式会社 ネフローゼ症候群治療剤
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
KR20080016735A (ko) * 2005-06-27 2008-02-21 각코우호우진 쥰텐도 헤르페스 바이러스 유래 동통 치료제
AU2007339153B2 (en) * 2006-12-26 2010-11-25 Taiho Pharmaceutical Co., Ltd. Therapeutic agent for diabetic neuropathy
US20100029590A1 (en) * 2007-02-14 2010-02-04 Prelief Inc. Methods for treating or preventing hemorrhagic cystitis using a glycerophosphate salt
US7902260B2 (en) * 2007-02-28 2011-03-08 Kemphys Ltd. Medicament for preventive and/or therapeutic treatment of lower urinary tract symptom
US20080275015A1 (en) * 2007-05-01 2008-11-06 Potter Jeffrey A Formulation and Method for Treating Interstitial Cystitis and Related Bladder Conditions
US20100210600A1 (en) * 2009-02-19 2010-08-19 Prelief Inc. Methods and Compositions for Treating Urogenital Disorders
WO2011065444A1 (ja) 2009-11-27 2011-06-03 学校法人東海大学 抗血栓剤
JP2022013721A (ja) * 2020-07-03 2022-01-18 大鵬薬品工業株式会社 排尿症状治療剤
JP6894555B1 (ja) * 2020-07-03 2021-06-30 大鵬薬品工業株式会社 排尿症状治療剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
GB2274241B (en) * 1993-01-19 1996-06-05 Rack Eng Improvements relating to pull-out shelf support systems
TW264385B (de) 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
WO1996033741A1 (fr) * 1995-04-24 1996-10-31 Taiho Pharmaceutical Co., Ltd. Remede pour maladies allergiques, a appliquer dans la region du nez

Also Published As

Publication number Publication date
KR20010033852A (ko) 2001-04-25
AU734793B2 (en) 2001-06-21
ATE413869T1 (de) 2008-11-15
CN1224384C (zh) 2005-10-26
JP3507439B2 (ja) 2004-03-15
CA2317530C (en) 2004-04-27
US6329428B1 (en) 2001-12-11
CN1287485A (zh) 2001-03-14
WO2000027383A1 (fr) 2000-05-18
EP1055426B1 (de) 2008-11-12
CA2317530A1 (en) 2000-05-18
EP1055426A4 (de) 2005-04-06
EP1055426A1 (de) 2000-11-29
AU1077900A (en) 2000-05-29
KR100375003B1 (ko) 2003-03-06

Similar Documents

Publication Publication Date Title
DE69939894D1 (de) Behandlung der dysurie
DZ1785A1 (fr) Nouveaux composés.
ATE262336T1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
CU23028A3 (es) Aminas novedosas como agentes farmaceuticos.
DE60324180D1 (de) Behandlung der huntington's krankheit mit epa
EA200301232A1 (ru) Новые соединения арилсульфонамида и их применение для лечения ожирения, диабета типа ii и нарушений центральной нервной системы
BRPI0410711B8 (pt) ácido 4-(acetilamina)-3-[(4-clorofenil)tio]-2-metil-1h-indol-1-acético
ATE256671T1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)- piperazin-derivate
DE3865099D1 (de) Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
ATE272398T1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
DE69827853D1 (de) Verwendung von ibudilast zur herstellung eines arzneimittels zur behandlung multiple sklerose
DE69936785D1 (de) Zellvermittelte genverabreichung durch verwendung von aus muskeln derivierten zellen zur behandlung der knochen-verwandten verletzung oder störung
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
DE69611598D1 (de) Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen
DK0682947T3 (da) Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi
ATE463242T1 (de) Behandlung von inkontinenz
DE3687692D1 (de) Geschlechtshormone zur behandlung von immun-mangel-krankheiten.
NO904575L (no) Benzocykloalkylaminopyridinaminer og beslektede forbindelser, mellomprodukter, fremgangsmaate for deres fremstillingog anvendelse som medikamenter.
ATE285773T1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
ATE330604T1 (de) Behandlung von manischen erkrankungen
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
FR2775976B1 (fr) Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase

Legal Events

Date Code Title Description
8364 No opposition during term of opposition